Filing Details

Accession Number:
0001104659-21-078411
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-06-08 20:56:23
Reporting Period:
2021-06-07
Accepted Time:
2021-06-08 20:56:23
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1297184 Amphastar Pharmaceuticals Inc. AMPH Pharmaceutical Preparations (2834) 330702205
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1379941 Howard Lee C/O Amphastar Pharmaceuticals, Inc.
11570 6Th Street
Rancho Cucamonga CA 91730
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-06-07 7,827 $16.43 140,741 No 4 M Direct
Common Stock Disposition 2021-06-07 7,827 $19.28 132,914 No 4 S Direct
Common Stock Acquisiton 2021-06-07 6,019 $0.00 138,933 No 4 A Direct
Common Stock Acquisiton 2021-06-08 8,000 $16.43 146,933 No 4 M Direct
Common Stock Disposition 2021-06-08 8,000 $19.31 138,933 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 A Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2021-06-07 7,827 $0.00 7,827 $16.43
Common Stock Stock Option (right to buy) Acquisiton 2021-06-07 17,182 $0.00 17,182 $19.52
Common Stock Stock Option (right to buy) Disposition 2021-06-08 8,000 $0.00 8,000 $16.43
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
8,000 2021-06-09 No 4 D Direct
17,182 2029-06-07 No 4 A Direct
0 2021-06-09 No 4 D Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.20 to $19.40 shares sold at each separate price within the ranges set forth in footnotes (1) and (3) to this Form 4.
  2. The reported shares are represented by restricted stock units, or RSUs, all of which vest on June 7, 2022.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.30 to $19.353, inclusive.
  4. Shares subject to the option are fully vested and immediately exercisable.
  5. All of the shares subject to the option vest on June 7, 2022.